Clinical trial
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain…
NCT00003478 · Duke University, Other · Completed
Key facts
| NCT number | NCT00003478 |
|---|---|
| Title | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors |
| Official title | Phase I Study of Intra-Tumoral, Radiolabeled, Anti-Tenascin Monoclonal Antibody 81C6 in the Treatment of Patients With Malignant Primary Brain Tumors |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Procedure, Radiation |
| Interventions | conventional surgery, iodine I 131 monoclonal antibody 81C6, radiation therapy |
| Enrollment | 10 |
| Start date | Oct 1, 1997 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: